Lesson 5 of 36 · 11 min

Approved, investigational & research-only

One of the most important skills in peptide research is recognising that ‘people use it’, ‘it worked in mice’, ‘there is a human study’ and ‘it is an approved medicine’ are completely different evidence statements.

Four different situations

Status tells you how much has actually been established.

Approved medicine

A regulator has reviewed evidence for a specific product, indication, manufacturing process and labeling. Approval is not a blanket endorsement of every possible use.

Clinical investigation

The compound is being studied in people, but the question may still be open. Phase, population, endpoint and study design matter.

Early or limited human evidence

There may be small trials, older studies or evidence in a narrow population. Interesting does not mean settled.

Preclinical / research-only

Evidence may come mainly from cells, tissues or animal models. These studies can explain biology without proving a human outcome.

How drugs move forward

Mechanism is the beginning of the story, not the end.

Drug development usually progresses from laboratory work into animal studies and then human trials designed to answer safety, dosing and efficacy questions. Approval requires a much broader package than a promising mechanism.

For a reader, this means you should always ask what kind of evidence produced the claim in front of you. A receptor mechanism, a rodent result and a randomized human trial should never be presented as if they carry the same weight.

✓Who or what was studied: cells, animals, healthy volunteers or patients?
✓Was there a comparison or control group?
✓Was the outcome clinically meaningful or just a laboratory marker?
✓How many people were studied and for how long?
✓Does the formulation and route match the product being discussed?

The Pep Report approach

Excitement and evidence can coexist.

A research-positive site does not need to flatten everything into ‘approved’ versus ‘bad’. Early research can be genuinely interesting. The job is to label the evidence honestly so the reader knows what kind of conclusion the study can support.

Key takeaways

✓Approved, investigational, limited-human and preclinical are different evidence states.
✓A biological mechanism does not by itself prove a useful human outcome.
✓Human evidence still varies enormously in quality and relevance.
✓Approval applies to a product and indication, not every claim made about a molecule.
✓Good research keeps the interesting signal while making the uncertainty visible.

Ready for the checkpoint?

The quiz opens on its own page. Get every answer correct to mark this lesson complete and continue.

Take lesson quiz →

The peptide landscape ←

Next lesson

Where peptide science is going →

Continue when you are ready, or come back to this lesson whenever you need a refresher.